Turkish Adaptation, Validity and Reliability Study of the Athlete Disability Index Questionnaire (ADI_Turkish)

November 19, 2025 updated by: Gülay Aras Bayram, Medipol University

Turkish Adaptation, Validity and Reliability Study

This survey study aims to analyze the cultural adaptation, validity, and reliability of a scale originally in English and currently being translated into Turkish, which allows athletes with low back pain to assess their functional disabilities in sports and exercise activities as well as their disabilities in daily living activities. Athletes with low back pain will be asked to fill out 3 questionnaires.

Study Overview

Status

Completed

Detailed Description

In the study, firstly, the translation of the Athlete Disability Index Questionnaire (ADI) into the target language, comparison of the two translated versions of the scale, back translation of the preliminary version, synthesis, pilot test of the pre-final version and psychometric test studies will be carried out by 3 independent translators and 2 linguists in 6 stages.

Then, 120 athletes with low back pain will be asked to fill out the ADI, Roland Morris Disability Questionnaire (RMDQ) and Oswestry Low Back Pain Disability Index (ODI). 7 days later, the ADI will be filled out again by 60 athletes.

After the surveys are completed, the structural validity of the scale will be tested, and reliability will be measured by performing test-retest reliability and internal consistency analyses.

Study Type

Observational

Enrollment (Actual)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beykoz
      • Istanbul, Beykoz, Turkey (Türkiye), 34810
        • Gülay Aras Bayram

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Male and female elite athletes from different sports with low back pain

Description

Inclusion Criteria:

  • Low back pain that has persisted for at least 6 weeks
  • Pain that worsens with changes in posture, movement, or physical activity
  • Elite athletes with a regular training/match schedule of more than 10 hours per week

Exclusion Criteria:

  • Not knowing Turkish
  • Acute inflammatory conditions
  • Acute musculoskeletal trauma
  • Long-term corticosteroid use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Athlete Disability Index Questionnaire (ADI)
Time Frame: 7 days
The Athlete Disability Index Questionnaire (ADI) is a self-administered questionnaire to assess disability related to low back pain in athletes. The ADI measures athletes' functional disability in activities of daily living as well as their disability in sports and exercise activities. The ADI consists of 12 questions that include pain intensity, stretching exercises, strengthening/weight training exercises, sport-specific skills (technical skills), rotational waist movements/changing direction, fear of pain or re-injury, sitting, walking, recreational activities, sexual activity, sleep, and personal care (ability to put on socks and shoes, ability to go to the bathroom). Each question is scored from 0 to 3, with higher scores indicating a more severe condition.
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry Low Back Pain Disability Index (ODI)
Time Frame: 1 day

Oswestry Low Back Pain Disability Index (ODI) is a Likert-type scale that questions pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sexual life, social life and traveling in 10 items. Each item is scored between 0-5 (0: normal, 5: maximum difficulty) and the total score is 50.

In it's calculation; (Final score = [total score] / [(number of marked questions) x5] x 100) formula is used to convert it to a percentage system. A high percentage indicates that the level of disability perceived by the patient is also high. Turkish validity and reliability study has been conducted.

1 day
Roland Morris Disability Questionnaire (RMDQ)
Time Frame: 1 day
Roland Morris Disability Questionnaire (RMDQ): This scale, which was developed by selecting 24 of the 136 items of the Disease Impact Profile, evaluates activity level, daily living activities, eating and sleeping. Yes is scored as 1, no is scored as 0, and a higher total score indicates worse functionality. A Turkish validity and reliability study was conducted by Küçükdeveci et al.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gülay Aras Bayram, PhD, Medipol University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 27, 2025

Primary Completion (Actual)

June 2, 2025

Study Completion (Actual)

June 10, 2025

Study Registration Dates

First Submitted

November 20, 2024

First Submitted That Met QC Criteria

November 20, 2024

First Posted (Actual)

November 22, 2024

Study Record Updates

Last Update Posted (Actual)

November 20, 2025

Last Update Submitted That Met QC Criteria

November 19, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Survey using a questionnaire.

Subscribe